Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | lysine (K)-specific methyltransferase 2A | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0403 | 0.5 |
Brugia malayi | hypothetical protein | 0.0043 | 0.5379 | 0.4985 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.1968 | 0.1537 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0403 | 0.5 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.1968 | 0.1265 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0403 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0076 | 1 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.1968 | 0.1283 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 1 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.443 | 0.443 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.1968 | 0.1537 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.5058 | 0.4637 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0403 | 0.5 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0403 | 0.5 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0403 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.5379 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.1968 | 0.1265 |
Echinococcus granulosus | cpg binding protein | 0.0037 | 0.443 | 0.4131 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0403 | 0.5 |
Onchocerca volvulus | 0.0035 | 0.4154 | 0.5 | |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.1968 | 0.1968 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.1968 | 0.1968 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.5379 | 0.5 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0805 | 0.0311 |
Trichomonas vaginalis | helicase, putative | 0.0008 | 0.0403 | 0.5 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0035 | 0.4154 | 0.3642 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.5379 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.5058 | 0.5058 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.5379 | 0.5131 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.0509 | 0.0509 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.5379 | 0.5379 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.1968 | 0.1537 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0403 | 0.5 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0805 | 0.0311 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.1968 | 0.1968 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0403 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 1 | 1 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0066 | 0.8491 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.7722 | 0.7522 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0403 | 0.5 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.1968 | 0.1537 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.443 | 0.443 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.7722 | 0.7522 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.5379 | 0.5379 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.5379 | 0.5 |
Echinococcus multilocularis | cpg binding protein | 0.0037 | 0.443 | 0.4131 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.1968 | 0.1283 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.7722 | 0.7527 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 1 | 1 |
Brugia malayi | CXXC zinc finger family protein | 0.0035 | 0.4154 | 0.3655 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.5058 | 0.4626 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.1968 | 0.1537 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.1968 | 0.1537 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0403 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0403 | 0.5 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0074 | 0.959 | 0.959 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.7722 | 0.7527 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.5379 | 0.5131 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.1968 | 0.1968 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0403 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0403 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0403 | 0.5 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.4154 | 0.4154 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0403 | 0.5 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0403 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 20.5878 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 32.6427 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.